These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 34021503)

  • 21. Protocol for a Korean Multicenter Prospective Cohort Study of Active Surveillance or Surgery (KoMPASS) in Papillary Thyroid Microcarcinoma.
    Jeon MJ; Kang YE; Moon JH; Lim DJ; Lee CY; Lee YS; Kim SW; Kim MH; Kim BH; Kang HC; Shong M; Cho SW; Kim WB
    Endocrinol Metab (Seoul); 2021 Apr; 36(2):359-364. PubMed ID: 33752303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Active Surveillance for Patients With Papillary Thyroid Microcarcinoma: A Single Center's Experience in Korea.
    Kwon H; Oh HS; Kim M; Park S; Jeon MJ; Kim WG; Kim WB; Shong YK; Song DE; Baek JH; Chung KW; Kim TY
    J Clin Endocrinol Metab; 2017 Jun; 102(6):1917-1925. PubMed ID: 28323932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors.
    Shi C; Guo Y; Lv Y; Nanding A; Shi T; Qin H; He J
    PLoS One; 2016; 11(12):e0167414. PubMed ID: 27936049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Margin Positivity and Survival in Papillary Thyroid Microcarcinoma: A National Cancer Database Analysis.
    Lee CI; Kutlu O; Khan ZF; Picado O; Lew JI
    J Am Coll Surg; 2021 Oct; 233(4):537-544. PubMed ID: 34265429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can Active Surveillance be an Alternative to Surgery in Papillary Thyroid Microcarcinoma?: The Current Situation Worldwide.
    Aygün N; İşgör A; Uludağ M
    Sisli Etfal Hastan Tip Bul; 2018; 52(4):233-243. PubMed ID: 32774084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Papillary thyroid microcarcinoma: how to diagnose and manage this epidemic?
    Soares P; Celestino R; Gaspar da Rocha A; Sobrinho-Simões M
    Int J Surg Pathol; 2014 Apr; 22(2):113-9. PubMed ID: 24401191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Outcomes Following Thyroid Isthmusectomy, Unilateral Thyroid Lobectomy, and Total Thyroidectomy in Patients with Papillary Thyroid Microcarcinoma of the Thyroid Isthmus: A Retrospective Study at a Single Center.
    Gui Z; Wang Z; Xiang J; Sun W; He L; Dong W; Huang J; Zhang D; Lv C; Qin Y; Zhang T; Shao L; Zhang P; Zhang H
    Med Sci Monit; 2020 Dec; 26():e927407. PubMed ID: 33351790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Position paper from the Japan Thyroid Association task force on the management of low-risk papillary thyroid microcarcinoma (T1aN0M0) in adults.
    Horiguchi K; Yoshida Y; Iwaku K; Emoto N; Kasahara T; Sato J; Shimura H; Shindo H; Suzuki S; Nagano H; Furuya F; Makita N; Matsumoto F; Manaka K; Mitsutake N; Miyakawa M; Yokoya S; Sugitani I
    Endocr J; 2021 Jul; 68(7):763-780. PubMed ID: 33762511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multifocality and total tumor diameter predict central neck lymph node metastases in papillary thyroid microcarcinoma.
    Zhao Q; Ming J; Liu C; Shi L; Xu X; Nie X; Huang T
    Ann Surg Oncol; 2013 Mar; 20(3):746-52. PubMed ID: 22972508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progression of Low-Risk Papillary Thyroid Microcarcinoma During Active Surveillance: Interim Analysis of a Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma in Korea.
    Lee EK; Moon JH; Hwangbo Y; Ryu CH; Cho SW; Choi JY; Chung EJ; Jeong WJ; Jung YS; Ryu J; Kim SJ; Kim MJ; Kim YK; Lee CY; Lee JY; Yu HW; Hah JH; Lee KE; Lee YJ; Park SK; Park DJ; Kim JH; Park YJ
    Thyroid; 2022 Nov; 32(11):1328-1336. PubMed ID: 36205563
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinicopathological features of papillary thyroid microcarcinoma with a diameter less than or equal to 5 mm.
    Yan L; Blanco J; Reddy V; Al-Khudari S; Tajudeen B; Gattuso P
    Am J Otolaryngol; 2019; 40(4):560-563. PubMed ID: 31103218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Papillary thyroid carcinoma and microcarcinoma: is there a need to distinguish the two?
    Arora N; Turbendian HK; Kato MA; Moo TA; Zarnegar R; Fahey TJ
    Thyroid; 2009 May; 19(5):473-7. PubMed ID: 19348582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Retrospective comparison of screening criteria for active surveillance for papillary thyroid microcarcinoma].
    Qian K; Sun TQ; Guo K; Zheng XK; Li DS; Wei WW; Wu Y; Ji QH; Wang ZY
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 52(6):430-434. PubMed ID: 28635215
    [No Abstract]   [Full Text] [Related]  

  • 34. Recommend with caution: A meta-analysis investigating papillary thyroid carcinoma tumor progression under active surveillance.
    Issa PP; Munshi R; Albuck AL; Omar M; Abu Alhuda RF; Metz T; Hussein M; Shama M; Lee GS; Toraih E; Kandil E
    Am J Otolaryngol; 2023; 44(6):103994. PubMed ID: 37607459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Features of papillary thyroid microcarcinoma associated with lateral cervical lymph node metastasis.
    Jeon MJ; Chung MS; Kwon H; Kim M; Park S; Baek JH; Song DE; Sung TY; Hong SJ; Kim TY; Kim WB; Shong YK; Lee JH; Kim WG
    Clin Endocrinol (Oxf); 2017 Jun; 86(6):845-851. PubMed ID: 28273370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multifocality and Progression of Papillary Thyroid Microcarcinoma During Active Surveillance.
    Nagaoka R; Ebina A; Toda K; Jikuzono T; Saitou M; Sen M; Kazusaka H; Matsui M; Yamada K; Mitani H; Sugitani I
    World J Surg; 2021 Sep; 45(9):2769-2776. PubMed ID: 34100116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BRAF V600E status may facilitate decision-making on active surveillance of low-risk papillary thyroid microcarcinoma.
    Kim KJ; Kim SG; Tan J; Shen X; Viola D; Elisei R; Puxeddu E; Fugazzola L; Colombo C; Jarzab B; Czarniecka A; Lam AK; Mian C; Vianello F; Yip L; Riesco-Eizaguirre G; Santisteban P; O'Neill CJ; Sywak MS; Clifton-Bligh R; Bendlova B; Sýkorová V; Xing M
    Eur J Cancer; 2020 Jan; 124():161-169. PubMed ID: 31790974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RISK FACTORS FOR CENTRAL LYMPH NODE METASTASES IN PATIENTS WITH PAPILLARY THYROID MICROCARCINOMA.
    Wu X; Li B; Zheng C; He X
    Endocr Pract; 2018 Dec; 24(12):1057-1062. PubMed ID: 30289307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Routine Chest Computed Tomography at Presentation Does Not Identify Distant Metastasis in cT1aN0 Papillary Thyroid Carcinoma.
    Kawano S; Miyauchi A; Ito Y
    Thyroid; 2020 Nov; 30(11):1620-1624. PubMed ID: 32368954
    [No Abstract]   [Full Text] [Related]  

  • 40. Active Surveillance of Thyroid Microcarcinoma-Can This Approach Be Safely Implemented Worldwide?
    Pollack R; Mazeh H
    J Surg Res; 2021 Feb; 258():145-152. PubMed ID: 33010560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.